The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Amplyx announced positive topline data following the completion of its trial of fosmanogepix for invasive fungal infections caused by Candida.
read more
BioAegis has received regulatory clearance from The Spanish Agency for Medicines and Health Products for its study of recombinant human plasma ...
read more
AstraZeneca Pharmaceuticals
AstraZeneca has been granted Fast Track Designation for Farxiga to reduce the risk of hospitalization for hHF or cardiovascular death in adults ...
read more
Akebia announced the initiation of a study evaluating vadadustat, as a potential therapy to prevent and lessen the severity of ARDS, a complication of...
read more
10x Genomics has launched its Chromium Single Cell Immune Profiling v2 product.
read more
The Hackensack Meridian CDI announced a research collaboration with Merck to investigate drugs for treating COVID-19.
read more
Immutep has announced the grant of patent no. 10,711,060 entitled “Antibody molecules to LAG-3 and uses thereof” by the United States Patent and Trade...
read more
Enzychem has filed an IND to the FDA for a trial of EC-18 as a preventative therapeutic against ARDS due to COVID-19 pneumonia.
read more
Angelini will be responsible to develop, manufacture and commercialize OV101 for the potential treatment of Angelman syndrome.
read more
Rigel announced the initiation of an IST being conducted by Imperial College London to evaluate the efficacy of fostamatinib, its oral SYK inhibitor, ...
read more
Janssen Research & Development
Janssen Pharmaceutical announced the FDA has approved TREMFYA® for adult patients with active psoriatic arthritis.
read more
Granules is voluntarily recalling 12 lots of Metformin Hydrochloride Extended-Release Tablets due to the detection of NDMA levels above the Acceptable...
read more
Mylan and Fujifilm Kyowa Kirin Biologics announced the FDA has approved Hulio for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic ...
read more
Assembly Biosciences announced the FDA has granted Fast Track designation to ABI-H2158 for chronic HBV infection.
read more
Creative Medical Technology announced completion of preclinical studies assessing the anti-inflammatory and neuroregenerative activities of AmnioStem™...
read more